tetano
Editor, Senior Moderator
Pathogens
. 2020 Nov 26;9(12):E989.
doi: 10.3390/pathogens9120989.
The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections
Alexey A Lozhkov[SUP] 1 2 [/SUP], Sergey A Klotchenko[SUP] 2 [/SUP], Edward S Ramsay[SUP] 2 [/SUP], Herman D Moshkoff[SUP] 3 4 [/SUP], Dmitry A Moshkoff[SUP] 1 2 4 5 [/SUP], Andrey V Vasin[SUP] 1 2 5 6 [/SUP], Maria S Salvato[SUP] 5 7 [/SUP]
Affiliations
Abstract
Interferons (IFN) are crucial for the innate immune response. Slightly more than two decades ago, a new type of IFN was discovered: the lambda IFN (type III IFN). Like other IFN, the type III IFN display antiviral activity against a wide variety of infections, they induce expression of antiviral, interferon-stimulated genes (MX1, OAS, IFITM1), and they have immuno-modulatory activities that shape adaptive immune responses. Unlike other IFN, the type III IFN signal through distinct receptors is limited to a few cell types, primarily mucosal epithelial cells. As a consequence of their greater and more durable production in nasal and respiratory tissues, they can determine the outcome of respiratory infections. This review is focused on the role of IFN-λ in the pathogenesis of respiratory viral infections, with influenza as a prime example. The influenza virus is a major public health problem, causing up to half a million lethal infections annually. Moreover, the virus has been the cause of four pandemics over the last century. Although IFN-λ are increasingly being tested in antiviral therapy, they can have a negative influence on epithelial tissue recovery and increase the risk of secondary bacterial infections. Therefore, IFN-λ expression deserves increased scrutiny as a key factor in the host immune response to infection.
Keywords: influenza; innate immunity; interferon stimulated genes; interferons-α/β; interferons-λ; respiratory viruses.
. 2020 Nov 26;9(12):E989.
doi: 10.3390/pathogens9120989.
The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections
Alexey A Lozhkov[SUP] 1 2 [/SUP], Sergey A Klotchenko[SUP] 2 [/SUP], Edward S Ramsay[SUP] 2 [/SUP], Herman D Moshkoff[SUP] 3 4 [/SUP], Dmitry A Moshkoff[SUP] 1 2 4 5 [/SUP], Andrey V Vasin[SUP] 1 2 5 6 [/SUP], Maria S Salvato[SUP] 5 7 [/SUP]
Affiliations
- PMID: 33255985
- DOI: 10.3390/pathogens9120989
Abstract
Interferons (IFN) are crucial for the innate immune response. Slightly more than two decades ago, a new type of IFN was discovered: the lambda IFN (type III IFN). Like other IFN, the type III IFN display antiviral activity against a wide variety of infections, they induce expression of antiviral, interferon-stimulated genes (MX1, OAS, IFITM1), and they have immuno-modulatory activities that shape adaptive immune responses. Unlike other IFN, the type III IFN signal through distinct receptors is limited to a few cell types, primarily mucosal epithelial cells. As a consequence of their greater and more durable production in nasal and respiratory tissues, they can determine the outcome of respiratory infections. This review is focused on the role of IFN-λ in the pathogenesis of respiratory viral infections, with influenza as a prime example. The influenza virus is a major public health problem, causing up to half a million lethal infections annually. Moreover, the virus has been the cause of four pandemics over the last century. Although IFN-λ are increasingly being tested in antiviral therapy, they can have a negative influence on epithelial tissue recovery and increase the risk of secondary bacterial infections. Therefore, IFN-λ expression deserves increased scrutiny as a key factor in the host immune response to infection.
Keywords: influenza; innate immunity; interferon stimulated genes; interferons-α/β; interferons-λ; respiratory viruses.